C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 47/48 (2006.01) C07K 14/33 (2006.01) C12N 11/02 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2158647
This invention describes a novel agent for the targeted control of a mammalian cell activity, in particular the agent is used to control the interaction of particular cell types with their external environment. The agent has applications as a pharmaceutical for the treatment of a variety of disorders. An agent according to the invention comprises three Domains B, T and E linked together in the following manner: Domain B--Domain T--Domain E where Domain B is the Binding Domain which binds the agent to a Binding Site on the cell which undergoes endocytosis to produce an endosome, Domain T is the Translocation Domain which translocates the agent (with or without the Binding Site) from within the endosome across the endosomal membrane into the cytosol of the cell, Domain E is the Effector Domain which inhibits the ability of the Recyclable Membrane Vesicles to transport the Integral Membrane Proteins to the surface of the cell.
Foster Keith Alan
North John Robert
Quinn Conrad Padraig
Shone Clifford Charles
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Syntaxin Limited
LandOfFree
Conjugate containing botulinum toxin translocation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugate containing botulinum toxin translocation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugate containing botulinum toxin translocation and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1682203